CD163 and breast cancer: Working in the same line, in vivo studies showed that BC supplementation inhibited the expression of the CD206, Arg1, Ym-1, CD163, and PPAR-g M2 macrophage markers in an azoxymethane/dextran sodium sulfate (DSS)-induced colitis-associated CRC mouse model.